NCT04725357

Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?

A Randomized Comparison of Meloxicam to Opioids Following Arthroscopic Labrum Repairs of the Shoulder

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 96 (estimated)
• Sponsor: Rothman Institute Orthopaedics · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The opioid epidemic continues to be a major concern, with orthopedic surgeons being among the top prescribers of opioids. Studies evaluating these practices found that opioids are overprescribed, even for common procedures. Patients undergoing arthroscopic labrum repair of the shoulder were found to have an average of 20 pills left over after surgery. Many strategies have been developed to tackle overprescribing and have found success, including no opioid protocols for carpal tunnel release. The purpose of this study is to examine if meloxicam alone provides similar patient reported outcomes to opioids following arthroscopic labrum repair of the shoulder.

Conditions

• Shoulder Pain

Interventions

Type	Name	Description
DRUG	Meloxicam 15 mg	Participants will receive a prescription of 20 pills of 15 mg Meloxicam after surgery
PROCEDURE	Preoperative Interscalene Nerve Block	Preoperatively participants will standardly receive an interscalene nerve block
PROCEDURE	arthroscopic labral repair	participant will have their standard surgical procedure done

Timeline

• Start date: 2021-01-25
• Primary completion: 2022-01-25
• Completion: 2022-01-25
• First posted: 2021-01-26
• Last updated: 2021-01-26

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study